Converting Hazardous Drug (HD) Rooms to Non-HD Use
A central question addressed is whether a hazardous drug (HD) compounding room can be converted into a non-hazardous (non-HD) space.
The answer: Yes, but it is complex and requires significant effort.
Key considerations include:
- Reconfiguring room pressure differentials
- Working with certifiers to adjust facility controls
- Ensuring the space meets requirements for non-HD compounding
The process is not straightforward and requires careful planning.
Managing Hazardous Drug Residue During Conversion
The most critical concern in converting an HD room is residual contamination.
Hazardous drug residue can persist on:
- Surfaces
- Equipment
- Filters
To safely convert the space, facilities must:
- Perform thorough decontamination
- Use repeated cleaning cycles
- Conduct surface (wipe) sampling to measure residue levels
The goal is to reduce contamination to acceptable (near-zero) levels to prevent patient exposure.
Equipment and Facility Considerations (PECs & SECs)
Equipment used in HD compounding may retain contamination and require additional action.
Key considerations include:
- Replacing HEPA filters in PECs (Primary Engineering Controls)
- Evaluating impact on SECs (Secondary Engineering Controls)
- Assessing whether equipment can be safely reused
Filters and internal components may harbor hazardous drug residue, making replacement necessary in some cases.
Environmental Monitoring and Surface Sampling
Wipe sampling is emphasized as a critical tool for evaluating contamination levels.
Facilities must:
- Perform surface sampling after cleaning
- Track residue levels (e.g., nanograms of contamination)
- Continue decontamination until acceptable thresholds are reached
Sampling provides objective data to support safe conversion decisions.
Practical Challenges and Operational Considerations
The panel highlights that converting HD rooms is often more difficult than anticipated.
Challenges with converting HD rooms include:
- Time and labor required for decontamination
- Cost of equipment replacement (e.g., filters)
- Complexity of validating a clean environment
- Risk of incomplete residue removal
As a result, conversion is often not recommended as a temporary solution due to the effort involved.
Risk-Based Decision Making in Facility Changes
The discussion reinforces the importance of risk-based decision making.
Facilities must weigh:
- Patient safety risks
- Operational burden
- Regulatory expectations
The presence of residual hazardous drugs poses a direct risk to patients if non-HD medications are compounded in contaminated environments.
Decisions should prioritize safety and long-term compliance rather than short-term convenience.
Contec Healthcare
Compounding Pharmacy, Webinar
return to overview
back to top